CN427

CAS No. ——

CN427( CN-427 | CN 427 )

Catalog No. M17055 CAS No. ——

CN427 (CN-427) is novel BRD4 (BD1, 2) inhibitor with IC50 of 66 nM, MV4-11 viability IC50 of 1.1 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CN427
  • Note
    Research use only, not for human use.
  • Brief Description
    CN427 (CN-427) is novel BRD4 (BD1, 2) inhibitor with IC50 of 66 nM, MV4-11 viability IC50 of 1.1 uM.
  • Description
    CN427 (CN-427) is novel BRD4 (BD1, 2) inhibitor with IC50 of 66 nM, MV4-11 viability IC50 of 1.1 uM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CN-427 | CN 427
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    Bromodomain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    496.571
  • Molecular Formula
    C28H28N6O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OCCN1N=CC(C2=NC(N3C(C4=CC=CC=C4)COCC3)=C5C=C(C6=C(C)ON=C6C)C=CC5=N2)=C1
  • Chemical Name
    2-(4-(6-(3,5-dimethylisoxazol-4-yl)-4-(3-phenylmorpholino)quinazolin-2-yl)-1H-pyrazol-1-yl)ethan-1-ol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yang SM, et al. Bioorg Med Chem Lett. 2018 Nov 15;28(21):3483-3488.
molnova catalog
related products
  • Mivebresib

    Mivebresib (ABBV-075) is a potent and orally available BET bromodomain inhibitor with Ki of 1.0, 12.2, 1.5, and 2.2 nM for BRD2, BRD3, BRD4 and BRDT, respectively.

  • Y08060

    Y08060 is a potent and selective BET inhibitor with Kd of 306 nM for BRD4 BD1.

  • BET-BAY 002

    BET-BAY 002 is a potent BET bromodomain inhibitor; shows efficacy in a multiple myeloma model.